However, the inhibition of C5a, a major neutrophil chemoattractant, by IFX-1 failed to demonstrate a significant difference in hidradenitis suppurativa clinical response 50 (HiSCR50) compared with placebo [31]. The gene discussed is C5AR1; the disease is hidradenitis suppurativa.